Page last updated: 2024-09-05

me 3221 and bradykinin

me 3221 has been researched along with bradykinin in 1 studies

Compound Research Comparison

Studies
(me 3221)
Trials
(me 3221)
Recent Studies (post-2010)
(me 3221)
Studies
(bradykinin)
Trials
(bradykinin)
Recent Studies (post-2010) (bradykinin)
70014,1953551,520

Protein Interaction Comparison

ProteinTaxonomyme 3221 (IC50)bradykinin (IC50)
B2 bradykinin receptorHomo sapiens (human)0.0018

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fujishima, K; Hachisu, M; Hui, C; Katano, K; Kawano, K; Konno, F; Nagura, J; Ogino, H; Yamamoto, M; Yasuda, S1

Other Studies

1 other study(ies) available for me 3221 and bradykinin

ArticleYear
Pharmacological profile of ME3221, a novel angiotensin II receptor antagonist.
    European journal of pharmacology, 1995, Feb-14, Volume: 274, Issue:1-3

    Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Aorta, Thoracic; Biphenyl Compounds; Blood Pressure; Bradykinin; Callithrix; Disease Models, Animal; Drug Evaluation; Female; Femoral Artery; Heart Rate; Hypertension, Renal; Imidazoles; Losartan; Male; Rabbits; Rats; Rats, Inbred SHR; Rats, Sprague-Dawley; Species Specificity; Tetrazoles

1995